Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)

Past Federal grant forecast Posted

Opportunity number
PAR-27-049
Agency
Applications expected due
Award size
Not on record

Opportunity facts

Expected posting
Funding instrument
Grant
Category
  • Health
Eligible applicants
  • Tribal Governments (Federally Recognized)
  • Independent School Districts
  • Higher Education Inst. (Private)
  • Special District Governments
  • Higher Education Inst. (Public)
  • Tribal Organizations (Not Federally Recognized)
  • For Profit Organizations
  • State Governments
  • County Governments
  • Small Businesses
  • 501(c)(3) Nonprofits
  • City/Township Governments
  • Non-501(c)(3) Nonprofits
  • Other
  • Public or Indian Housing Auth.
Points of contact

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institutes of Health is soliciting applications for ancillary studies to ongoing clinical projects, with no specified application deadline. This forecast opportunity is open to a broad range of applicant types including higher education institutions (public and private), state and local governments, tribal governments and organizations, nonprofits, for-profit organizations, small businesses, and faith-based or community-based organizations; eligible applicants also include federal agencies, U.S. territories, and non-domestic entities.

Ancillary studies must leverage privately or publicly funded, active, ongoing parent projects—including interventional clinical trials, observational studies, or disease-specific repositories actively collecting patient samples or clinical data. The parent project must provide a cohort of well-characterized patients, infrastructure, data, and biological samples. The objective is to provide a flexible mechanism to maximize return on existing research investments by enhancing scientific content and value, improving disease or organ system understanding, and identifying novel targets for diagnosis, treatment, and prevention.

This opportunity is assigned to two federal grant programs: Arthritis, Musculoskeletal and Skin Diseases Research (CFDA 93.846) and Aging Research (CFDA 93.866). No cost share is specified. Award ceilings, floors, expected number of awards, period of performance, and place of performance details are not provided in the forecast notice. Standard NIH evaluation criteria assess scientific merit, investigator competency, technical adequacy, facility adequacy, budget necessity, and relevance to program objectives.

Forecast synopsis

This Notice of Funding Opportunity (NOFO) solicits applications that propose to conduct time-sensitive ancillary studies in conjunction with privately or publicly funded, active, ongoing clinical projects (parent projects). The parent project can be an interventional clinical trial, or a clinical study such as an observational study, or a disease-specific repository that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. The objective of this NOFO is to provide a flexible mechanism to leverage currently funded resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community's understanding of a disease or organ system and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity